This article has been cited by other articles in PMC.
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (356K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Fine HA, Mayer RJ. Primary central nervous system lymphoma. Ann Intern Med. 1993 Dec 1;119(11):1093–1104.[PubMed]
Lundberg PO, Osterman PO, Wide L. Serum prolactin in patients with hypothalamus and pituitary disorders. J Neurosurg. 1981 Aug;55(2):194–199.[PubMed]
Ross RJ, Grossman A, Bouloux P, Rees LH, Doniach I, Besser GM. The relationship between serum prolactin and immunocytochemical staining for prolactin in patients with pituitary macroadenomas. Clin Endocrinol (Oxf) 1985 Sep;23(3):227–235.[PubMed]
Bevan JS, Burke CW, Esiri MM, Adams CB. Misinterpretation of prolactin levels leading to management errors in patients with sellar enlargement. Am J Med. 1987 Jan;82(1):29–32.[PubMed]
Rillema JA, Lawson DM. Identification of two specific prolactin binding sites on Nb2 rat lymphoma cells. Proc Soc Exp Biol Med. 1994 Jan;205(1):75–79.[PubMed]
Pellegrini I, Lebrun JJ, Ali S, Kelly PA. Expression of prolactin and its receptor in human lymphoid cells. Mol Endocrinol. 1992 Jul;6(7):1023–1031.[PubMed]
Gellersen B, DiMattia GE, Friesen HG, Bohnet HG. Regulation of prolactin secretion in the human B-lymphoblastoid cell line IM-9-P3 by dexamethasone but not other regulators of pituitary prolactin secretion. Endocrinology. 1989 Dec;125(6):2853–2861.[PubMed]
Grobe N, Rühle H, Eckelmann G. Hyperprolactinämie bei malignen Lymphomen. Dtsch Med Wochenschr. 1990 Nov 30;115(48):1825–1827.[PubMed]
Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press